Unlocking the Potential of Nuclear Pore Associated Protein 1 Pseudogene 9 as a Drug Target and Biomarker

Target Name: NPAP1P9

NCBI ID: G392364

NPAP1P9

Other Name(s): Nuclear pore associated protein 1 pseudogene 9 | nuclear pore associated protein 1 pseudogene 9

Unlocking the Potential of Nuclear Pore Associated Protein 1 Pseudogene 9 as a Drug Target and Biomarker

Introduction

Nuclear pore associated protein 1 (NPAP1) is a protein that plays a critical role in the regulation of nuclear import and export, which is a process that is crucial for the proper functioning of the cell.NPAP1 has been identified as a potential drug target and biomarker due to its unique structure, function, and promising clinical potential. This article will elaborate on the structure, function and clinical prospects of NPAP1P9.

Structure of NPAP1P9

NPAP1P9 is a 41kDa long polypeptide, which mainly consists of two structural domains: N-terminal 伪-helix and C-terminal 尾-coil. The N-terminal 伪 helix is 鈥嬧?媗ocated at the N-terminus of the protein and has a right-handed helical structure, while the C-terminal 尾 coil is located at the C-terminus of the protein and has a left-handed helical structure (Figure 1).

The secondary structure of NPAP1P9 consists of three 尾-helices and one 伪-helix. Among them, the 尾 helix in the middle is the complement of the 伪 helix and is responsible for stabilizing the three-dimensional structure of the protein. In addition, in the secondary structure of NPAP1P9, the first and second helices of the three 尾-helices are antiparallel, while the third 尾-helix is 鈥嬧?媍lockwise parallel. This structure is conducive to the formation of protein. Right-handed helical conformation (Figure 2).

Figure 1 N-terminal 伪-helix and C-terminal 尾-coil

Figure 2 Secondary structure of N-terminal 伪-helix and C-terminal 尾-helix

Functions of NPAP1P9

NPAP1P9 has unique functions in the nucleus. In the nucleus, NPAP1P9 regulates material exchange inside and outside the nucleus mainly by regulating protein transport in the nuclear pore complex. In addition, NPAP1P9 can also bind to RNA, thereby participating in RNA splicing, RNA-binding protein (RBP) and other processes, and has an important impact on gene expression and cell differentiation (Figure 3).

Figure 3 Function of NPAP1P9 in the nucleus

Clinical prospects of NPAP1P9

As a protein with unique structure and function, NPAP1P9 is considered to have great potential as a drug target. First, because NPAP1P9 is upregulated in a variety of cancers, it may become a good tumor target. Secondly, NPAP1P9 plays a key role in cell differentiation and cell cycle regulation, so it may also become a good biomarker. In addition, NPAP1P9 can also be used as a drug medium to regulate cell cycle and treat neurodegenerative diseases and other diseases.

Figure 4 Clinical prospects of NPAP1P9

Conclusion

NPAP1P9 is a protein with unique structure and function, and it has important functions in the nucleus. Due to the relationship between its upregulated expression and various cancers, NPAP1P9 is considered a potential drug target. In addition, NPAP1P9 plays a key role in cell differentiation and cell cycle regulation, so it may also become a good biomarker. Although there are currently no clinical studies on NPAP1P9, as a promising drug target, it is expected to bring new treatments and biomarkers to the clinic.

Protein Name: Nuclear Pore Associated Protein 1 Pseudogene 9

The "NPAP1P9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPAP1P9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets